113 - Mano-a-Mano V: Pediatric Infectious Diseases

10/4/2019

10:30 AM - 11:45 AM

Room: Walter E. Washington Convention Center, Salon GHI

MOC Credit: Maximum of 1.25 hours of MOC Credit
CME Credit: Maximum of 1.25 hours of AMA PRA Category 1 Credit™
ACPE Credit: ACPE 1.25 knowledge-based contact hours of pharmacy CE
ACPE Number: 0221-9999-19-361-L01-P

Learning Objectives:

At the conclusion of this session, participants will be able to:

discuss how pre-transplant viral infections impacts post-transplant outcomes
discuss how pre-transplant viral infections do not affect post-transplant outcomes
discuss the pros of reverse syphilis algorithms
discuss the cons of reverse syphilis screening algorithms
describe when to use steroids for children who have an abnormal ECHO and Kawasaki Disease
explain when to use Infliximab for children who have an abnormal ECHO and Kawasaki Disease

Presentations:

10:30 AM - 10:42 AM
926 - Pre-Transplant Resp Viral Infection Impacts Post-Transplant Outcomes Infection: PRO
Alpana Waghmare, MD – University of Washington
10:42 AM - 10:54 AM
927 - Pre-Transplant Resp Viral Infection Impacts Post-Transplant Outcomes Infection: CON
Flor M. Munoz, MD – Baylor College of Medicine
10:54 AM - 11:04 AM
928 - Reverse Syphilis Screening Algorithms: PRO
Pablo J. Sanchez, MD – Nationwide Children's Hospital
11:04 AM - 11:16 AM
929 - Reverse Syphilis Screening Algorithms: CON
Laura H. Bachmann, MD – Centers for Disease Control and Prevention
11:16 AM - 11:28 AM
930 - Use of Steroids versus Infliximab in Kawasaki Disease for an Abnormal ECHO: PRO Steroids
Preeti Jaggi, MD – Emory University
11:28 AM - 11:45 AM
931 - Use of Steroids versus Infliximab in Kawasaki Disease for an Abnormal ECHO: PRO Infliximab
Jane Burns, MD – University of California, San Diego

Debate Style Speaker(s)

Laura Bachmann, MD

Chief Medical Officer, Division of STD Prevention
Centers for Disease Control and Prevention
Atlanta, GA

Disclosure: Nothing to disclose
Jane Burns, MD

Professor
University of California, San Diego
La Jolla, CA

Disclosure: Nothing to disclose
PJ

Preeti Jaggi, MD

Associate Professor of Pediatrics
Emory University
Atlanta, GA

Disclosure: Nothing to disclose
Flor Munoz, MD

Associate Professor of Pediatrics
Baylor College of Medicine
Houston, TX

Disclosure: Biocryst: Grant/Research Support
CDC: Research Grant
Moderna: Other Financial or Material Support, Safety Monitoring Board Member/Chair
NIH: Research Grant
Novavax: Research Grant
UP to Date: Author and Editor - Royalties, Other Financial or Material Support
PS

Pablo Sanchez, MD

Professor or Pediatrics
Nationwide Children's Hospital
Columbus, Ohio

Disclosure: Merck: Grant/Research Support
Alpana Waghmare, MD

Assistant Professor
University of Washington
Seattle, WA

Moderator(s)

Natasha Halasa, MD, MPH

Associate Professor
Vanderbilt University Medical Center
Nashville, Tennessee

Disclosure: Moderna: Consultant
Sanofi Pasteur: Grant/Research Support, vaccine and HAI testing
Tara Greenhow, MD

Regional Lead Pediatric Infectious Diseases
Kaiser Permanente Northern California
San Francisco, CA

Disclosure: Nothing to disclose